Investigating the causes for decreased levels of glutathione in individuals with type II diabetes.
Tuberculosis (TB) remains an eminent global burden with one third of the world's population latently infected with Mycobacterium tuberculosis (M. tb). Individuals with compromised immune systems are especially vulnerable to M. tb infection. In fact, individuals with Type 2 Diabetes Mellitus (T2...
Main Authors: | Minette Lagman, Judy Ly, Tommy Saing, Manpreet Kaur Singh, Enrique Vera Tudela, Devin Morris, Po-Ting Chi, Cesar Ochoa, Airani Sathananthan, Vishwanath Venketaraman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4366217?pdf=render |
Similar Items
-
The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering the Immune Responses against Mycobacterium bovis BCG Strain in Individuals with Type 2 Diabetes
by: To Kimberly, et al.
Published: (2021-05-01) -
Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
by: Kimberly To, et al.
Published: (2021-06-01) -
Glutathione synthesis is compromised in erythrocytes from individuals with HIV
by: Vishwanath eVenketaraman
Published: (2014-04-01) -
Glutathione Supplementation as an Adjunctive Therapy in COVID-19
by: Vika Guloyan, et al.
Published: (2020-09-01) -
The association of pulmonary fibrosis with diabetes mellitus
by: Niranjan Jeganathan, et al.
Published: (2020-11-01)